Prot # 052-00: A Phase II/III Randomized Clinical Trial to Study the Efficacy and Safety of the Combination Regimen of MK-5172 and MK-8742 in Subjects with Chronic Hepatitis C Virus Infection and Chronic Kidney Disease

Project: Research project

Project Details

StatusFinished
Effective start/end date3/4/143/4/17

Funding

  • Merck Sharp & Dohme Corporation (Prot # 052-00)